MedPath

doxycycline

doxycycline hyclate capsules

Approved
Approval ID

1496c935-b2dc-e1e4-e063-6394a90a1e49

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 26, 2024

Manufacturers
FDA

Medsource Pharmaceuticals

DUNS: 833685915

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

doxycycline

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code45865-203
Application NumberANDA209402
Product Classification
M
Marketing Category
C73584
G
Generic Name
doxycycline
Product Specifications
Route of AdministrationORAL
Effective DateMarch 26, 2024
FDA Product Classification

INGREDIENTS (10)

FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
DOXYCYCLINE HYCLATEActive
Quantity: 100 mg in 1 1
Code: 19XTS3T51U
Classification: ACTIM
POTASSIUM HYDROXIDEInactive
Code: WZH3C48M4T
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

doxycycline - FDA Drug Approval Details